Fast answers matter. What happens next matters too.

When a patient calls an oncology practice, a quick answer can make the first moment easier. But answering the phone is only the beginning.

The caller may need an appointment change, help with a referral, a records update, or a message sent to the clinical team. The quality of the interaction depends on whether that need is understood and handled appropriately.

A useful patient-access review connects three questions: Did the caller reach someone? Was the request handled within the approved workflow? Was the next step clear?

CDAS-reported results from an oncology access program include a 99.04% service level, an eight-second average speed of answer, and 0.45% call abandonment. These are historical program results, not promises about every future engagement.

Alongside access performance, CDAS audits 100% of call and message data. In-house-built AI tools support seasoned QA executives in identifying communication issues, documentation gaps, routing trends, and coaching needs.

For practice leadership, the value is a fuller picture of the service. A strong answer-speed figure should sit alongside evidence that requests are documented, exceptions are escalated, and recurring issues receive attention.

Patients experience that discipline in practical ways: a clearer explanation, a properly documented request, and an understandable next step.

The takeaway: Measure access and follow-through together.